JRUB:XETRA JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc

EUR 103.87 -0.27 -0.259266
Icon

JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc (JRUB:XETRA) Stock Analysis and Price Targets

ETF | Others | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 103.87

-0.27 (-0.26)%

EUR 5.96B

209.00

EUR -1.00

N/A

Icon

JRUB:XETRA

JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc (EUR)
ETF | XETRA
EUR 103.87
0.00 0
Take a Tour

JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc (JRUB:XETRA) Stock Forecast

N/A

Based on the JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc stock forecast from 0 analysts, the average analyst target price for JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc is not available over the next 12 months. JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc is Neutral, which is based on 2 positive signals and 2 negative signals. At the last closing, JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc’s stock price was EUR 103.87. JPMorgan ETFs Ireland ICAV - USD Corporate Bond Research Enhanced Index ESG UCITS ETF USD Acc’s stock price has changed by -0.18% over the past week, +0.08% over the past month and +4.18% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...